BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 810634)

  • 1. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
    Brüning G
    Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
    Schuster CJ; von Ungern-Sternberg AF
    ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
    Wampola H
    Fortschr Med; 1977 May; 95(18):1240,1242-5. PubMed ID: 405291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical treatment of peripheral arterial occlusive diseases].
    Schulte B
    Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma levels and biliary and urinary elimination of raubasine, dehydroergocristine and dihydroergotamine after venous administration in anesthetized dogs].
    Marzo A; Ghirardi P; Parenti MA; Merlo L; Marchetti G
    Boll Soc Ital Biol Sper; 1975 Jun; 51(11):684-6. PubMed ID: 816365
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
    Lesch OM; Musalek M; Dietzel M; Grünberger J; Saletu B; Schjerve M; Walter H; Werner U; Zeiler K
    Wien Med Wochenschr; 1985 Sep; 135(18):459-65. PubMed ID: 3933188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative rheographic study of the effects of a new drug combination: raubasine/dihydroergocristine].
    Henriet M; Jacquy J; Noel G
    Brux Med; 1974 Dec; 54(12):743-5. PubMed ID: 4215548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J
    Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment by sandoven-f in patients with venous affections (author's transl)].
    Viviani E
    Schweiz Rundsch Med Prax; 1975 Oct; 64(41):1320-3. PubMed ID: 815900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of eutergine in chronic cerebral arteriopathies].
    Pauchant M; Bernard JM
    Lille Med; 1972 May; 17():Suppl 4:819-23. PubMed ID: 4626797
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical test of Iskedyl in cochlear and vestibular chronic diseases].
    Muler H; Prache H
    Ann Otolaryngol Chir Cervicofac; 1976; 93(4-5):325-7. PubMed ID: 821378
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of peripheral vasodilator drug in peripheral and cerebrovascular syndromes of old age].
    Andalò L; Missana M
    Clin Ter; 1975 Sep; 74(5):471-84. PubMed ID: 819202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 19. Electroencephalogram and ergot alkaloids.
    Venn RD
    Postgrad Med J; 1976; 52suppl 1():55-6. PubMed ID: 822408
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.